INTRODUCTION
Third molar extraction, one of the most common oral surgeries performed, is associated with considerable pain and discomfort. Numerous studies have been conducted to identify optimal analgesics for the relief of pain and discomfort following third molar extraction. The analgesic efficacy of COX 2 inhibitors, including celecoxib, valdecoxib and non-steroidal anti-inflammatory drugs (NSAID), such as ibuprofen, and opioids, such as oxycodone have been studied for pain management in oral surgery [1, 2] . Preemptive analgesia with dexamethasone alone or co-administered with either ibuprofen or diclofenac sodium were investigated [3, 4] . Different formulations of the same medication, such as diclofenac sodium softgel were also investigated [5] . All studies have shown promising results but these studies used only oral medications for pain control. Adverse effects of NSAID medication, which is the mainstay of treatment for third molar extraction surgery, might be varied. These effects include nausea, gastritis, gastro intestinal hemorrhage, analgesic nephropathy, and coagulation defect. Local anesthetics, including bupivacaine and lignocaine hydrochloride with methyl prednisolone have been shown to reduce post-operative pain and swelling following third molar extraction. However, only the intraoperative conditions were observed [6, 7] .
Reduced consumption of topical morphine or ketamine after tonsillectomy has been reported [8] . No definitive outcomes have been reported with regards to the use of oral rinses, mouthwashes, and sprays for recovery after post tonsillectomy pain [9] .
Topical administration of NSAIDs might help in reducing side effects without actually decreasing the quality of analgesia. Benzydamine hydrochloride, a topical NSAID, has been studied and found to be effective for treating oral mucositis and oral ulcers, as well as for the prevention of post-operative sore throat following endotracheal intubation [10] [11] [12] . Amidst the plethora of studies not much has been experimented with the use of topical oral analgesic rinse in third molar extraction surgery. We hypothesized that analgesic mouth rinses can reduce the use of oral analgesics, thus reducing the side effects associated with oral analgesic use without compromising the quality of analgesia. In this study, our aim was to assess analgesic requirement and patient satisfaction after using topical oral analgesic benzydamine hydrochloride mouthwash and after using only oral analgesics.
METHODS
A randomized controlled trial was conducted in a tertiary care specialized oral and maxillofacial unit. As this was a pilot study, each group comprised 40 cases. 
Randomization, blinding and allocation concealment:
Randomization was performed using a sequence of random numbers generated by the RALLOC software.
The two intervention mouth-rinses bottles were numbered as per the random number table. Allocation concealment was performed using the "SNOSE technique." The random number table was kept with the administrative head.
The patient and operator were not blinded, however the person collecting the post-operative data was blinded.
Patients could not be blinded because benzydamine hydrochloride is sweet, slightly stinging in taste with a peppermint odor, and has a clear yellowish-green color and normal saline is clear and salty in taste. The operator could not be blinded because the two liquids have different colors and odors. The person writing the prescription was not involved in the further study.
Intervention
Once the patient was enrolled in the study, two minutes before the extraction he/she was given a mouth wash labeled A or B as per randomization and thereafter, extraction was performed by a single experienced surgeon who has performed more than 1000 extractions. The inferior alveolar, long buccal branch of mandibular, and lingual nerves were blocked during the extraction. Patients recorded the number of times brushing was done per day and use of gargles in the prescribed form which was provided.
Base-line parameters: age (years), sex, reason for extraction (periodontitis, caries, or prophylactic), side of extraction, oral hygiene status (measured using the OHI-S index) [13] , time taken for extraction (< 5 minutes, 5-15 minutes, > 15 minutes), and any intra-operative complications were noted. After the extraction, difficulty index was assessed based on a modified Parant's index [14] for surgical extraction. Only those patients who fulfilled the criteria for the Type 1 (Easy) category of the Parant´s index were included in the study.
Outcome parameters with time-line
Patients performed self-evaluation at home. At the hospital, they were evaluated on the 3 rd and 7 th post-extraction day. Pain was assessed using the VAS.
Trismus was evaluated by using a simple grading system.
In this system, a score of 0 was assigned where trismus was absent, 1 was assigned when mouth opening was > 76% of normal, 2 was assigned when mouth opening was less than 75% and more than 51% of normal, 3 was assigned when mouth opening was less than 50% but more than 26% of normal, and 4 was assigned when mouth Although the ages of patients in both groups are statistically different, they are essentially all adults and belong to a similar physiological age range. Therefore, the age should not have any influence on the outcome of the study.
RESULTS

A total of 40 patients fulfilling the inclusion criteria
Dental carries was the single largest cause for third molar extraction, followed by prophylactic extraction and periodontitis. The reasons for extraction were similar in both groups with no statistical difference (P = 0.88). The time taken for extraction was less than 5 mins in majority of the cases with no significant statistical difference between the groups (P = 0.376). The OHI-S index was comparable in both groups (P = 0.376). Pain scores assessed by VAS determined the need for oral analgesics.
VAS on the 3 rd and 7 th PODs in group A was higher than that for group B but the difference was statistically insignificant (P = 0.436 and P = 0.9065, respectively).
Patients who used benzydamine hydrochloride oral rinse consumed less oral analgesics (5.25 ± 2.2, mean ± SD) as compared to patients who used normal saline gargle (6.05 ± 2.4, mean ± SD) on the 3 rd POD and 9.15 ± 5.9
Versus 10.65±6.5 respectively on 7 th POD, but the difference was statistically insignificant (P = 0.244 and P = 0.489, respectively). Comparison of trismus in both groups did not yield any statistical difference either on the 3 rd or 7 th POD (P = 0.609 and P = 0.490, respectively).
Similarly, patient satisfaction level was comparable in both groups on both 3 rd and 7 th PODs (P = 0.28 and P = 0.22, respectively). Thus, in summary, topical NSAID benzydamine hydrochloride did reduce the use of oral analgesic consumption as compared to the use of normal saline gargle but statistically the difference was insignificant. The satisfaction level after using benzydamine hydrochloride was same as that after using normal saline gargle as shown in Table 2 . Benzydamine hydrochloride {1-benzyl-3-[3(dimethylamino)
-propoxy]-1H-indazole hydrochloride} is a non-steroidal drug with anti-inflammatory, analgesic, and anti-microbial properties. The drug is believed to exert its effect by forming thromboxanes which decrease prostaglandin production leading to the stabilization of cell membranes and inhibition of platelet aggregation [15] .
Studies involving topical application of analgesics, such as morphine for oral mucositis in children [16] , and morphine and ketamine for post tonsillectomy pain [8] , have shown decrease in pain scores and less analgesic consumption in the postoperative period.
After comparing oral nimesulide with benzydamine hydrochloride oral rinses for inflammatory ear, nose, and throat diseases, it was shown that nimesulide had a more rapid effect and higher patient tolerability [17] .
Fedorowicz Z et al. reviewed studies on oral rinses, mouthwashes, and sprays for improving recovery following tonsillectomy but could not achieve a definitive outcome [9] . Sini and Ivan Djordjevi, compared benzydamine hydrochloride and salvia officinalis (artificial saliva) as adjuvant local treatments with systemic nonsteroidal anti-Inflammatory drugs [18] . In their study, which involved clinical trials on children and adults who underwent tonsillectomy, adenoidectomy, or both, benzydamine hydrochloride was more effective than saliva officinalis in controlling postoperative pain and infection.
The effect of benzydamine hydrochloride on pain relief was faster and persisted for one week after surgery. The safety profiles of both the formulations were the same.
Benzydamine hydrochloride was more efficacious in preventing postoperative infections in adults [18] .
In our study, we did not observe the benefits of topical benzydamine hydrochloride as demonstrated above. It is plausible that the drug works in adenotonsillectomy because the raw area along with the nerve endings are exposed allowing the topical medication to act. In mandibular 3 rd molar extraction, however, the wound is postoperative sore throat (POST) and they concluded that aspirin and benzydamine hydrochloride gargles were effective in significantly reducing the incidence and severity of POST [12] . Benzydamine hydrochloride produced a more prolonged effect than aspirin.
Diclofenac mouthwash has been evaluated for treating inflammatory conditions of the mouth and for periodontal surgery, and has been shown to be effective [19, 20, 21] .
A limitation of this study is that the study, being a pilot study, has a small sample size. The difference in age groups could have been eliminated by a larger sample size. Another limitation as that, since patients and the operator could not be blinded due to the taste and color of normal saline and benzydamine hydrochloride solutions, there may have been some bias.
In conclusion, benzydamine hydrochloride oral rinses reduce the intake of oral analgesics in an insignificant manner and is inadequate for pain relief following mandibular third molar extraction.
